Raptor Pharmaceutical Corp. Upgraded To Trade On The NASDAQ Global Market - Company To Present At The 32nd Annual Cowen Health Care Conference

Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) today announced that the Company has been upgraded to trade on the NASDAQ Global Market. Shares of Raptor's common stock began trading on the NASDAQ Global Market on February 29, 2012 and will continue to be traded under the ticker RPTP.

"As we continue to make progress towards potentially commercializing our first product, we see this as reinforcement that we have also progressed as a corporate entity since listing on the NASDAQ Capital Market," said Kim R. Tsuchimoto, Chief Financial Officer, Treasurer and Secretary of Raptor. "We believe the move to the NASDAQ Global Market could bring increased market exposure and liquidity to our shares among those who recognize and appreciate our ability to meet the listing qualifications for the NASDAQ Global Market."

The Company also announced that Christopher M. Starr, Ph.D., the Company's Chief Executive Officer, will present an overview of the company at the 32nd Annual Cowen Health Care Conference. Raptor's presentation will take place at the Boston Marriott Copley Place on Wednesday, March 7th at 9:20am ET.

A live audio webcast and 14-day archive of the Cowen presentation will be available at http://ir.raptorpharma.com/events.cfm